PREVENTION OF NSAID-INDUCED GASTRIC ULCER WITH MISOPROSTOL: MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

The Lancet

Volumn 332, Issue 8623, 1988, Pages 1277-1280

  Graham, DavidY ^a   Agrawal, NaurangM ^b   Roth, SanfordH ^c  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY   (United States)

^c Arthritis Center Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; MISOPROSTOL; NAPROXEN; PIROXICAM;

CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STOMACH ULCER;

ABDOMEN; ADULT; AGED; AGED, 80 AND OVER; ALPROSTADIL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; HUMAN; MALE; MIDDLE AGE; MISOPROSTOL; MULTICENTER STUDIES; OSTEOARTHRITIS; PAIN; PROBABILITY; RANDOM ALLOCATION; STOMACH ULCER; SUPPORT, NON-U.S. GOV'T;

EID: 0023697639     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(88)92892-9     Document Type: Article

References (40)

1. Utilization of nonsteroidal anti-inflammatory drugs
2. Nonsteroidal anti-inflammatory drug gastropathy
3. Nonsteroidal anti-inflammatory drugs and life threatening complications of peptic ulceration
4. NSAID-induced gastroduodenal damage: effect of ranitidine prophylaxis
5. A multi-centre double-blind comparison of ranitidine vs placebo in the prophylaxis of nonsteroidal anti-inflammatory drug (NSAID) induced lesions in gastric and duodenal mucosae
6. Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage
7. Perspective on the gastnc antisecretory effects of misoprostol m man
8. Mucosal protective activities of misoprostol in man: an overview
9. Reduction of aspirin-induced fecal blood loss with low dose misoprostol tablets in man
10. 1 analog on aspirin-induced gastric bleeding and secretion
11. Gastric protection by misoprostol against 1300 mg of aspirin an endoscopic study
12. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration
13. A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects
14. Protection by misoprostol against naproxen-induced gastnc mucosal damage
15. 1
16. 1 analog, in the treatment of duodenal ulcers: a multicenter double-blind study
17. From experiment to experience: side effects of nonsteroidal anti-inflammatory drugs
18. Clinical benefits and comparative safety of piroxicam: analysis of worldwide clinical trials data
19. Naproxen tolerability in the elderly. a summary report
20. Gastroscopic evaluation of anti-inflammatory agents
21. Gastroduodenal mucosa and dyspeptic symptoms m arthritic patients during chronic nonsteroidal anti-inflammatory drug use
22. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs
23. 2
24. A prospective endoscopic study of the effect oforudis and oruvail on the upper gastrointestinal tract in patients with osteoarthritis
25. Gastric cytoprotection
26. Cytoprotection of the gastrointestinal mucosa
27. Physiology and pharmacology of prostaglandins
28. Histological and microcirculatory changes m alcohol-induced gastric lesions in the rat. effect of prostaglandin cytoprotection
29. Are prostaglandins truly "cytoprotective"?
30. Protective effects of prostaglandins against gastric mucosal damage. current knowledge and proposed mechanisms
31. 2 prostaglandins of human gastnc mucus output
32. Gastroduodenal mucosal defense mechanisms and the action of nonsteroidal anti-inflammatory agents
33. Duodenal mucosal bicarbonate secretion in humans a brief review
34. 3(-) transport: characteristics and proposed role in acidity regulations and mucosal protection
35. Mechanisms of action of antisecretory drugs. Studies on isolated canine fundic mucosal cells
36. Role of endogenous prostaglandins in gastric secretion and mucosal defence
37. Mechanisms involved in gastric mucosal resistance to injury
38. A multi-center double-blind companson of ranitidine vs placeboo in the prophylaxis of nonsteroidal anti-inflammatory Drug (NSAID) induced lesions in gastnc and duodenal mucosae
39. Nature of the bleeding vessel in recurrently bleeding gastric ulcers
40. Sucralfate m the relief of gastrointestinal symptoms associated with nonsteroidal anti-inflammatory drugs